Inflammation and thyroid autoimmunity in patients with fibromyalgia
Keywords:
fibromyalgia, thyroid autoimmunity, interleukin 17Abstract
Fibromyalgia (FM) is chronic nondegenerative and noninflamatory disease. Since a long time central role for understanding about clinical symptoms of FM like pain perception, sleep changes and depressive symptoms have central and peripheral mechanisms of neuro-transmitter and neuro-endocrine regulation. The aim of the study is to investigate the link between some inflammatory markers, thyroid autoimmunity and pain threshold in patients with FM. In the study were included 43 women with FM with mean age 46.1±10.5 years. Of them 23 were in the age range 43-49 and 18 healthy controls. Twenty three (53,5%) of the women were menopausal, none of them took hormone replacement therapy. Euthyroid were 74.4% of the included women, 23.1% - hypothyroid (10.3% drug compensated, 12.3 noncompensated) and only one woman was hyperthyroid. Although we cannot confirm the presence of significant link between interleukin 17 and autonomic neuropathy in patients with FM (p=0.237), there is a marled correlation. There was no significant link between IL17 levels between patients with FM and healthy controls despite the tendency towards 3 time higher levels in FM (33.1±128.7 vs. 9.1±9.8). This results present that thyroid status assesment is important in patients with FM. There is no difference in IL17 levels between patients with and without thyroid autoimmunity.
There is no significant correlation between IL-17 and TSH levels. The clinical observation and assessment of patients leads to practical results, linked to establishment of hypothyroidism as a reason for FM in more than 30% of the patients.
There is a marked difference in the levels of interleukin 17 – higher in patients with fibromyalgia than in controls. This shows that the presence of inflammatory process can be linked to the clinical signs in patients with FM and this is a component of the mixed pain in fibromyalgia.
References
Reshkova V. Izsledvane na boleznenite tochki pri bolni s fibromialgiya, lechenie s razlichni grupi medikamenti. Disertatsiya za pridobivane na nauchno-obrazovatelnata stepen „Doktor”, Sofiya, 2013 g.
Anderberg UM. Comment on: Johns and Littlejohn. The role of sex hormones in pain response. Pain, 2000, 87: 109-111
Blotman, F., Branco, J. Fibromyalgia. 2007.
Bote, M.E., Garcia, J.J., Hinchado, M.D., Ortega, E. Fibromyalgia:anti-inflammatory and stress responses after acute moderate exercise. PloS One, 2014, e74524.
Buskila, D., Sanzi-Puttini, P. Fibromyalgia and autoimmune diseases: the pain behind autoimmunity. IMAJ, 2008, 10, 77-78.
Ferraccioli, G., Cavalieri, F., Salaffi, F. et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissu chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain) (editorial). J Rheumatol. 1990, 17, 869-872.
Ferraccioli, G., Guerra, P, Rizzi, V, Baraldo, M et all. Somatomedine C (IGF-1) levels decrease during acute change of stress related hormones. Revelances for fibromyalgia. J Rheumatol., 1994,21:1332-1334
Gibson, S. J., Littlejohn, G. O., Gorman, H. M. et al. Altered pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain. 1994, 58, 185-19394.
Gupta, A., Silman, A. Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthrits research and therapy, 2004, 6, 98-106
Jurell, K. C., Zanetos, M. A., Orsinelli, A. et al. A study of thyroid function and symptoms. J Of Musculoskel Pain. 1996, 4(3), 49-60.
Kim, Y. K., Myint, B. H., Lee, B. H. “Th1, Th2 and Th3 cytokine alteration in Schizophrenia”. Progress in neuropsychopharmacology and biological psychiatry, 2004, 28, 7, 1129-1134. 101.
Knipping, A. Clinic of rheumatology. Friesland. 1995.
Kosek, e at al. Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain- interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis. J. Neuroimunol., 2015, 280, 49-55
Kosek, E., Ekholm, J., Hansson, P. Sensory disfunction in fibromyalgia patients with implications for pathogenetic mechanism. Pain. 1996, 68, 357-393
Мendieta, Cruz- Aguilera, Villalpando et al. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. Journal of Neuroimmunology, 2016, 290, 22-25., Menzies, V., Lyon, D. Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol Res Nurs. 2010, 11(4), 387-394), Webster, J.I., Toneli, L., Sternberg, E.M. Neuroendocrine regulation of immunity. Annual Review of immunology. 2002, 20, 125-163
Mikkelson, M., Latikka, P., Kautiaine, H. et al. Muscle and bone pressure threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil. 1992, 27, 303-347.
О’Malley, P. G. et al. Treatment of Fibromyalgia with antidepressant. A meta-analysis. J Gen Intern Med. 2000, 15, 659-666.
Powell, GF, Brasel, JA, Raiti,S., Bizzard, RM. Emotional deprivation and growth retardation simulating idiopathic hypopituitaris. Endocrinologic evaluation of the syndrome. NEJM, 1967, 276: 1279-1283
Rodrigues-Pinto, I. Agmon-Levin, N., Howard, A., Shoenfeld, Y. 2014. Fibromyalgia and cytokines. Immunol. Lett. 161(2), 200-203.
Salemi, S., Rethage, J., Wollina et al. Detection of IL-1β, IL-6 and tumor necrosis factor α in scin of patients with fibromyalgia. J Reumatol. 2003, 30,146-150.
Smart, P., Waylonis, G., Hackshaw. Immunologic profile of patients with fibromyalgia. American J Phys Med Rehab. 1997, 76, 231-234.
Sturgill, J., McGee, E., Menzies, V. Unique cytokine Signature in Plasma of patients with fibromyalgia, Journal of Imm. Research, 2014, Article ID 938576.
Wallace, D., Margolin, K. Acute-anset fibromyalgia as a complication of interleukin 2 therapy. ACR 1994-S73.
Wolfe, F., Anderson, J., Harkness, D. et al. A prospective, longitudinal, multicenter study of service utilization and costs in FM. Arthr Rheum 1997, 40, 1560-70.
Xiao et al. Elevated serum high- sensitivity C-reactive protein levels in fibromyalgia syndrome petients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol.int, 2013, 33 (5), 1259-12649.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Valentina Reshkova, Z. Kamenov, A. Gateva, A. Tzakova, Z. Kolarov, R. Rashkov

This work is licensed under a Creative Commons Attribution 4.0 International License.